FAVA, PAOLO

FAVA, PAOLO  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 99 (tempo di esecuzione: 0.053 secondi).
Titolo Data di pubblicazione Autore(i) File
Activity Of Imatinib Mesilate In Metastatic Melanoma 2014 Savoia Paola; Fava Paolo
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 2021 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
After Surgery: Follow-Up Guidelines of Melanoma Patients 2013 Paolo Fava; Pietro Quaglino; Maria Grazia Bernengo; Paola Savoia
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 2021 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. 2017 Licciardello M, Giura M.T., Rozzo G., Marra E, Fava P., Astrua C., Contu V., Lista P., Fierro M.T., Quaglino P., Ribero, S.
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 2017 Queirolo, Paola; Dozin, Beatrice; Morabito, Anna; Banelli, Barbara; Piccioli, Patrizia; Fava, Cristiana; Leo, Claudio; Carosio, Roberta; Laurent, Stefania; Fontana, Vincenzo; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Battaglia, Angelo; Ascierto, Paolo A.; Capone, Mariaelena; Simeone, Ester; De Galitiis, Federica; Pagani, Elena; Cappellini, Gian Carlo Antonini; Marchetti, Paolo; Guida, Michele; Tommasi, Stefania; Mandalà, Mario; Merelli, Barbara; Quaglino, Pietro; Fava, Paolo; Guidoboni, Massimo; Romani, Massimo; Spagnolo, Francesco; Pistillo, Maria Pia*
Atopic dermatitis in a phenylketonuric untreated patient 2015 Fava p; Fierro MT; Brizio M; Marra E; Spada M; Bernengo MG
Attività clinica e modulazione immunologica di bexarotene a basse dosi: presentazione di un caso 2008 Quaglino Pietro; Marenco Federica; Fava Paolo; Bernengo Maria Grazia
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 2019 Pileri A.; Fava P.; Fuligni F.; Gunnella S.; Guglielmo A.; Astrua C.; Grandi V.; Simontacchi G.; Patrizi A.; Quaglino P.; Pimpinelli N.
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 2015 Novelli M; Fava P; Sarda C; Ponti R; Osella-Abate S; Savoia P; Bergallo M; Lisa F; Fierro MT; Quaglino P.
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response 2019 Ribero, Simone*; Malavenda, Ottavia; Fava, Paolo; Astrua, Chiara; Marra, Elena; Osella-Abate, Simona; Sanlorenzo, Martina; Caliendo, Virginia; Fierro, Maria Teresa; Quaglino, Pietro
Bullous pemphigoid is characterised by a reduction of skin-homing/circulating FOXP3+ Tregs and by a down-regulation of the IL-10 pathway 2012 Quaglino P; Antiga E; Novelli M; Nardò T; Fava P; Ponti R; Osella-Abate S; Caproni M; Fabbri P; Bernengo MG
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study 2022 Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A.
Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients 2016 Savoia, Paola; Ranghino, Andrea; Fava, Paolo
Clinical and pathological relevance of drug-induced vitiligo in patients treated for metastatic melanoma with anti-PD1 or BRAF/MEK inhibitors 2020 Ramondetta A.; Ribero S.; Conti L.; Fava P.; Marra E.; Broganelli P.; Caliendo V.; Picciotto F.; Guida M.; Ierro M.T.; Quaglino P.
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 2021 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 2013 Quaglino P; Nardò T; Fierro MT; Massaia M; Orsucci L; Fava P; Marenco F; Marra E; Savoia P; Vitolo U; Boccadoro M; Bernengo M.
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 2010 Fierro MT; Ponti R; Titli S; Fava P; Novelli M; Quaglino P; Bernengo MG
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation 2015 Brizio, Matteo; Fava, Paolo; Astrua, Chiara; Cavaliere, Giovanni; Savoia, Paola
Cutaneous Adverse Events Related To Treatment With Imatinib 2014 Savoia Paola; Fava Paolo